Dr. Fletcher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7777 Forest Ln
Ste D400
Dallas, TX 75230Phone+1 972-566-6647Fax+1 972-566-6496
Summary
- Dr. Matthew Fletcher is a pediatric hematologist/oncologist in Dallas, TX and is affiliated with Medical City Dallas and Texas Oncology. He received his medical degree from Louisiana State University School of Medicine and has been in practice 9 years. He is experienced in hemophilia, neutropenia, and allogeneic stem cell transplantation. He has more than 30 publications and over 500 citings.
Education & Training
- Louisiana State University School of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2008 - 2011
- Louisiana State University School of Medicine in New OrleansClass of 2008
- Rhodes CollegeB.A., Biology and Psychology, Cum Laude, 2000 - 2004
Certifications & Licensure
- TX State Medical License 2023 - 2026
- LA State Medical License 2011 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Hyundai Hope on Wheels Scholar 2013
- The Herbert Rothschild Award New Orleans Pediatric Society, 2008
Publications & Presentations
PubMed
- 212 citationsSubpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathwaysPatrick Raber, Paul Thevenot, Rosa A. Sierra, Dorota Wyczechowska, Daniel Halle
International Journal of Cancer. 2014-06-15 - 80 citationsPrompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer.Matthew Fletcher, Hailey Hodgkiss, Song Zhang, Rachel Browning, Colleen Hadden
Pediatric Blood & Cancer. 2013-08-01 - 186 citationsl-Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor CellsMatthew Fletcher, Maria E. Ramirez, Rosa A. Sierra, Patrick Raber, Paul Thevenot
Cancer Research. 2015-01-15
Journal Articles
- Subpopulations of Myeloid-Derived Suppressor Cells (MDSC) impair T cell responses through independent nitric oxide-related pathwaysRaber, P., Thevenot, P., Sierra, R., Wyczechowska, D., Halle, D., Ramirez, M., Ochoa, A., Fletcher, M., Velasco, C., Wilk, A., Reiss, K., Rodriguez, P., International Journal of Cancer, 1/15/2014
- Successful treatment of acquired hemophilia A with rituximab and steroids in a 5 year-old girlFletcher, M., Velez, M., Morales, J., Journal of Pediatric Hematology and Oncology, 1/1/2014
- Successful treatment of acquired hemophilia A with rituximab in a 5 year-old girl with intestinal perforation secondary to small bowel obstructionFletcher, M., Velez, M., Morales, J., Pediatric Blood and Cancer, 1/1/2012
- Join now to see all
Abstracts/Posters
- Allogeneic Stem Cell Transplantation Using Reduced Intensity Conditioning: A Case Series.Fletcher, M., Wall, L., Paris, K., Yu, L., Pediatric Blood and Marrow Transplant Consortium/American Society of Pediatric Hematology and Oncology Tandem Annual Meeting, Chicago, IL, 1/1/2014
- Modulation of T-cell responses through L-arginine metabolism: A new therapy from an old enemy.Fletcher, M., Ramirez, M., Sierra, R., Raber, P., Thevenot, P., Rodriguez, P., LSU Pediatrics Research Day, New Orleans, LA, 1/1/2014
- "Allogeneic Stem Cell Transplantation Using Reduced Intensity Conditioning: A Case Series."Fletcher, M., Wall, L., Paris, K., Yu, L., LSU Pediatrics Research Day, New Orleans, LA, 1/1/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: